Cigarette maker Philip Morris International (PMI) is acquiring the UK-based inhaled drug delivery solutions company Vectura for $1.2 billion as part of its ‘Beyond Nicotine’ strategy. Using its experience in inhalation and aerosolization, PMI is expanding into adjacent areas—including respiratory drug delivery and selfcare wellness. The company said its goal is to reach at least $1 billion in net revenues by 2025.   “The acquisition of Vectura, following the recently announced agreement to acqui...